This study will adapt TranS-C+BL for at-risk adolescents using health equity-informed implementation science methods.
This randomized trial will enroll 75 youth aged 12-18 at risk for STB and clinically significant sleep difficulties identified in primary care. The randomization that this study uses is a 2:1 allocation to compare TranS-C+BL Sleep Feedback vs. Sleep Feedback Alone.
Age
12–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adolescents (12-18)
Current moderate to severe depression as measured by the PHQ-9M with a total score of greater than or equal to 11
Current clinically significant sleep disturbance measured by the PHQ-9-M sleep item greater than or equal to 2.
English language fluency and literacy sufficient to engage in study protocol.
You may not be if
Evidence of obstructive sleep apnea,
Evidence of restless legs syndrome
Evidence of psychosis
Evidence of bipolar disorder
Evidence of a developmental disability precluding comprehension of study procedures per electronic health record and eligibility screening.
Clareo Health | Transdiagnostic Sleep and Circadian Intervention + Bright Light in Adolescents With Elevated Depression (TranS-C+BL)
